Abstract
Wilson’s disease (WD) is a rare metabolic disorder caused by variations in the ATP7B gene. It usually manifests hepatic, neurologic, and psychiatric symptoms due to excessive copper accumulation. The prevalence of WD and its common variants differ across populations. This study aimed to examine these aspects of WD within the Thai population, where information has been limited. We reviewed ClinVar and the Wilson Disease Mutation Database, organizing variants classified as pathogenic or likely pathogenic in one or both databases as “relaxed” and “strict” lists. Allele frequencies were estimated from genotyping array data (Asian Screening Array: ASA; Illumina Corp, CA) of 6291 Thai subjects, which also underwent genotype imputation. The prevalence of WD in the Thai population was estimated assuming Hardy-Weinberg Equilibrium. The strict list yielded a prevalence of 1/24,128 (carrier frequency=1/78), while the relaxed list yielded a prevalence of 1/9971 (carrier frequency=1/50). The most common WD variants in Thai subjects were c.2333 G > T, c.3443 T > C, and c.813 C > A from the strict list, and c.3316 G > A and c.2605 G > A from the relaxed list. The ASA chip covered approximately 59 and 24% of WD variants from the strict and relaxed lists, respectively. Based on the estimated prevalence, a carrier screening program for WD is not currently required in Thailand. However, as genotyping services become more affordable and accessible, such a program would facilitate early identification, treatment, and prevention of WD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
At the moment, the ASA data set is available upon request from the corresponding author (jakrise@gmail.com). We plan to deposit the data on the National Science and Technology Development Agency (NSTDA) website under the Genomics Thailand programme in the future.
References
Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, et al. Wilson disease. Nat Rev Dis Prim. 2018;4:1–20.
Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev. 2007;87:1011–46.
Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–7.
Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: Impact on genetic testing [Internet]. Hum Genet. 2006;120:151–9. http://www.medgen.med.ualberta.ca.
Gomes A, Dedoussis GV. Geographic distribution of ATP7B mutations in Wilson disease. Ann Hum Biol. 2016;43:1–8.
Scheinberg IH, Sternlieb I. Wilson’s Disease. Philadelphia: W. B. Saunders; 1984.
Coffey AJ, Durkie M, Hague S, McLay K, Emmerson J, Lo C, et al. A genetic study of Wilson’s disease in the United Kingdom. Brain. 2013;136:1476–87.
Jang JH, Lee T, Bang S, Kim YE, Cho EH. Carrier frequency of Wilson’s disease in the Korean population: A DNA-based approach. J Hum Genet [Internet]. 2017;62:815–8. https://doi.org/10.1038/jhg.2017.49.
Gao J, Brackley S, Mann JP. The global prevalence of Wilson disease from next-generation sequencing data. Genet Med [Internet]. 2019;21:1155–63. https://doi.org/10.1038/s41436-018-0309-9.
Tai CS, Wu JF, Chen HL, Hsu HY, Chang MH, Ni YH. Modality of treatment and potential outcome of Wilson disease in Taiwan: A population-based longitudinal study. J Formos Med Assoc [Internet]. 2018;117:421–6. https://doi.org/10.1016/j.jfma.2017.05.0080929-6646/CCBY-NC-NDlicense.
Choe EJ, Choi JW, Kang M, Lee YK, Jeon HH, Park BK, et al. A population-based epidemiology of Wilson’s disease in South Korea between 2010 and 2016. Sci Rep. 2020;10:14041.
Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The Prevalence of Wilson’s Disease: An Update. Hepatol [Internet]. 2020;71:722–32. https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30911.
Wallace DF, Dooley JS. ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet. 2020;139:1065–75. https://doi.org/10.1007/s00439-020-02161-3.
Cheung KS, Seto WK, Fung J, Mak LY, Lai CL, Yuen MF. Epidemiology and natural history of Wilson’s disease in the Chinese: A territory-based study in Hong Kong between 2000 and 2016. World J Gastroenterol. 2017;23:7716–26.
Park HD, Ki CS, Lee SY, Kim JW. Carrier frequency of the R778L, A874V, and N1270S mutations in the ATP7B gene in a Korean population. Clin Genet. 2009;75:405–7. https://pubmed.ncbi.nlm.nih.gov/19419418/.
Bylstra Y, Kuan JL, Lim WK, Bhalshankar JD, Teo JX, Davila S, et al. Population genomics in South East Asia captures unexpectedly high carrier frequency for treatable inherited disorders. Genet Med. 2019;21:207–12. http://www.hgmd.cf.ac.uk.
Vathesatogkit P, Woodward M, Tanomsup S, Ratanachaiwong W, Vanavanan S, Yamwong S, et al. Cohort profile: The electricity generating authority of Thailand study. Int J Epidemiol. 2012;41:359–65. https://academic.oup.com/ije/article/41/2/359/690712.
Aekplakorn W, Chariyalertsak S, Kessomboon P, Sangthong R, Inthawong R, Putwatana P, et al. Prevalence and management of diabetes and metabolic risk factors in Thai adults: The Thai national health examination survey IV, 2009. Diabetes Care. 2011;34:1980–5. https://diabetesjournals.org/care/article/34/9/1980/38644/Prevalence-and-Management-of-Diabetes-and.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet [Internet]. 2007;81:559–75.
Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: Rising to the challenge of larger and richer datasets. Gigascience [Internet]. 2015;4:7 https://academic.oup.com/gigascience/article-lookup/10.1186/s13742-015-0047-8.
Purcell S, Chang C. PLINK 1.9. [cited 2021 Mar 22]. Available from: https://www.cog-genomics.org/plink/1.9/.
Purcell S, Chang C. PLINK 2.0. [cited 2021 Apr 7]. Available from: https://www.cog-genomics.org/plink/2.0/.
Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529.
Howie B, Marchini J, Stephens M. Genotype imputation with thousands of genomes. G3 Genes. 2011;1:457–70. http://www.g3journal.org/lookup/.
Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience [Internet]. 2021 Feb [cited 2022 Jul 23];10. Available from: https://pubmed.ncbi.nlm.nih.gov/33590861/.
Delaneau O, Howie B, Cox AJ, Zagury JF, Marchini J. Haplotype estimation using sequencing reads. Am J Hum Genet. 2013;93:687–96.
Weir BS. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, Massachusetts: Sinauer; 1996. p. 33.
Graffelman J, Weir BS. The transitivity of the Hardy-Weinberg law. Forensic Sci Int Genet [Internet]. 2022;58:102680 https://www.ncbi.nlm.nih.gov/pubmed/35313226.
Zheng HF, Ladouceur M, Greenwood CMT, Richards JB. Effect of Genome-Wide Genotyping and Reference Panels on Rare Variants Imputation. J Genet Genomics. 2012;39:545–50.
The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1092 human genomes. Nature. 2012;491:56–65. https://www.nature.com/articles/nature11632.
Park RHR, McCabe P, Fell GS, Russell RI. Wilson’s disease in Scotland. Gut. 1991;32:1541–5.
Cheng N, Wang K, Hu W, Sun D, Wang X, Hu J, et al. Wilson Disease in the South Chinese Han Population. Can J Neurol Sci [Internet]. 2014;41:363–7. https://doi.org/10.1017/S0317167100017315.
Wijayasiri P, Hayre J, Nicholson ES, Kaye P, Wilkes EA, Evans J, et al. Estimating the clinical prevalence of Wilson’s disease in the UK. JHEP Rep. [Internet]. 2021;3:100329 http://www.jhep-reports.eu/article/S2589555921001051/fulltext.
Lo C, Bandmann O. Epidemiology and introduction to the clinical presentation of Wilson disease. 1st ed. Vol. 142, Handbook of Clinical Neurology. Elsevier B.V.; 2017. 7–17. https://doi.org/10.1016/B978-0-444-63625-6.00002-1.
Song MJ, Lee ST, Lee MK, Ji Y, Kim JW, Ki CS. Estimation of carrier frequencies of six autosomal-recessive Mendelian disorders in the Korean population. J Hum Genet. 2012;57:139–44. https://www.nature.com/articles/jhg2011144.
Mak CM, Lam CW, Tam S, Lai CL, Chan LY, Fan ST, et al. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: Identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet [Internet]. 2008;53:55–63. http://www.gdb.org/gdb/.
Kim GH, Yang JY, Park JY, Lee JJ, Kim JH, Yoo HW. Estimation of Wilson’s disease incidence and carrier frequency in the Korean population by screening ATP7B major mutations in newborn filter papers using the SYBR green intercalator method based on the amplification refractory mutation system. Genet Test. 2008;12:395–9.
Vital Statistics of the United States. Vol II. Mortality; part A, Table 1-23, 1968-1978.
Bachmann H, Lössner J, Gruss B, Ruchholtz U. The epidemiology of Wilson’s disease in the German Democratic Republic and current problems from the viewpoint of population genetics. Psychiatr Neurol Med Psychol. 1979;31:393–400.
Saito T. An assessment of efficiency in potential screening for Wilson’s disease. J Epidemiol Community Health. 1981;35:274–80.
Park S, Park JY, Kim GH, Choi JH, Kim KM, Kim JB, et al. Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease. Hum Mutat. 2007;28:1108–13.
Tatsumi Y, Hattori A, Hayashi H, Ikoma J, Kaito M, Imoto M, et al. Current state of Wilson disease patients in central Japan. Intern Med [Internet]. 2010;49:809–15. http://joi.jlc.jst.go.jp/JST.JSTAGE/internalmedicine/49.2931?from=CrossRef.
Dong Y, Ni W, Chen WJ, Wan B, Zhao GX, Shi ZQ, et al. Spectrum and classification of ATP7B variants in a large cohort of Chinese patients with Wilson’s disease guides genetic diagnosis. Theranostics. 2016;6:638–49.
Panichareon B, Taweechue K, Thongnoppakhun W, Aksornworanart M, Pithukpakorn M, Yenchitsomanus Pthai, et al. Six novel ATP7B mutations in Thai patients with Wilson disease. Eur J Med Genet. 2011;54:103–7. https://doi.org/10.1016/j.ejmg.2010.10.008.
Pham LAT, Nguyen TT, Nga Le HB, Tran DQ, Ho CT, Tran TH, et al. Genetic analysis of 55 northern Vietnamese patients with Wilson disease: seven novel mutations in ATP7B. J Genet. 2017;96:933–9. https://doi.org/10.1007/s12041-017-0857-9.
Wei Z, Huang Y, Liu A, Diao S, Yu Q, Peng Z, et al. Mutational characterization of ATP7B gene in 103 Wilson’s disease patients from Southern China: Identification of three novel mutations. Neuroreport. 2014;25:1075–80.
Hua R, Hua F, Jiao Y, Pan Y, Yang X, Peng S, et al. Mutational analysis of ATP7B in Chinese Wilson disease patients. Am J Transl Res. 2016;8:2851–61.
Aggarwal A, Chandhok G, Todorov T, Parekh S, Tilve S, Zibert A, et al. Wilson disease mutation pattern with genotype-phenotype correlations from Western India: Confirmation of p.C271* as a common indian mutation and identification of 14 novel mutations. Ann Hum Genet. 2013;77:299–307. https://pubmed.ncbi.nlm.nih.gov/23551039/.
Committee Opinion No 690. Carrier screening in the age of genomic medicine. Obstet Gynecol. 2017;129:e35–40. https://journals.lww.com/greenjournal/Fulltext/2017/03000/Committee_Opinion_No__690__Carrier_Screening_in.47.aspx.
Gregg AR, Aarabi M, Klugman S, Leach NT, Bashford MT, Goldwaser T, et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:1793–806. http://www.gimjournal.org/article/S1098360021051200/fulltext.
Acknowledgements
The original SNP array assay was jointly funded by Faculty of Medicine Ramathibodi Hospital and the Department of Medical Sciences, Ministry of Public Health, Thailand. NGS was funded by the Health Systems Research Institute of Thailand through Mahidol University. The authors are thankful to the Research Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, especially Ms. Aruchalean Taweewongsounton, Ms. Supranee Thongpradit, and Ms. Preeyaporn Wichakong for performing the SNP array assay. We would like to express our gratitude to Dr. Wasun Chantratita and the Center for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, for providing the facilities for NGS processing and analysis. We greatly appreciate Ms. Nartthawee Thongchompoo for carrying out the NGS work and Mr. Sommon Klumsathian for his helpful advice for doing NGS data analysis. Finally, we thank the staff of both facilities, as well as professors and friends from the Program in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, for their ongoing support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Own-eium, P., Dejsuphong, D., Vathesatogkit, P. et al. Investigating common mutations in ATP7B gene and the prevalence of Wilson’s disease in the Thai population using population-based genome-wide datasets. J Hum Genet (2024). https://doi.org/10.1038/s10038-024-01292-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s10038-024-01292-z